A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD

Authors:
  • OGon Behalf of the LADD.CAT Study Group
    on Behalf of the LADD.CAT Study Group

Abstract
Objective: To assess the safety, tolerability, and effectiveness of mixed amphetamine salts extended release (MAS XR) in school-age children with attention-deficit/hyperactivity disorder (ADHD) treated in a community practice setting.Methods: Children aged 6–12 years (N = 2968) with DSM‐IV-defined ADHD entered a 9‐week prospective, open-label, non-comparative study of MAS XR at 386 sites. For at least 2 weeks before enrollment, subjects with well-controlled ADHD received their consistent dose of previously prescribed psychostimulant. Subsequently, this regimen was converted to an equivalent once-daily dose of 10-, 20-, or 30‐mg MAS XR, according to a conversion algorithm. Tolerability and safety were assessed based on reported treatment-emergent adverse events and observed changes in vital signs and body weight. Effectiveness was assessed using a parent-completed Conners’ Global Index Scale (CGIS‐P) measured 8 and 12 h postdose and a clinician-scored Clinical Global Impressions-Improvement (CGI‐I)...

This publication has 13 references indexed in Scilit: